Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism H-PGDS inhibitors(hematopoietic prostaglandin D synthase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Brain Infarction | Discovery | - | 26 Oct 2023 | |
| Digestive System Disorders | Discovery | - | 26 Oct 2023 | |
| Ischemic nephropathy | Discovery | - | 26 Oct 2023 | |
| Other Diseases | Discovery | - | 26 Oct 2023 | |
| Respiratory Diseases | Discovery | - | 26 Oct 2023 | |
| Skin and Musculoskeletal Diseases | Discovery | - | 26 Oct 2023 |





